Irbesartan E Idroclorotiazide Sandoz

Irbesartan/Hydrochlorothiazide, the active ingredient in Irbesartan E Idroclorotiazide Sandoz, is an Angiotensin II receptor blocker / Thiazide diuretic presented as a tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Irbesartan E Idroclorotiazide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan/Hydrochlorothiazide acts on the renin‑angiotensin‑aldosterone system and renal sodium handling to lower blood pressure. - Hypertension: reduces systolic and diastolic blood pressure in adults. - Diabetic nephropathy: slows progression of renal impairment associated with diabetes. - Cardiovascular risk reduction: helps lower the risk of stroke and other hypertensive complications.

Common Side Effects: - Dizziness: light‑headed sensation, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: feeling unusually tired or weak. - Increased urination: more frequent need to void. - Electrolyte imbalance: low potassium or sodium levels. - Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat requiring emergency care. - Severe allergic reaction: rash, itching, or hives with possible anaphylaxis. - Acute kidney injury: sudden loss of kidney function. - Hyperkalemia: dangerously high potassium levels. - Severe dehydration: excessive fluid loss leading to low blood pressure. - Blood dyscrasias: rare abnormalities in blood cell counts.

Before starting therapy, consider the following precautions. - Monitor blood pressure: ensure target levels are achieved without excessive drop. - Assess renal function: check serum creatinine and eGFR periodically. - Check electrolytes: especially potassium and sodium levels. - Avoid use in pregnancy: drug is classified as Category D and may harm the fetus. - Use caution in elderly patients: increased sensitivity to hypotension and electrolyte shifts. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Irbesartan/Hydrochlorothiazide may interact with several medicines. Major Interactions (Avoid): - Aliskiren: combined renin‑angiotensin blockade can increase renal impairment risk. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - NSAIDs: can blunt antihypertensive effect and worsen renal function. - Lithium: increased lithium levels leading to toxicity. - ACE inhibitors: additive effects on potassium and renal function.

Moderate Interactions (Monitor Closely): - Other thiazide diuretics: monitor electrolytes for additive diuretic effect. - Beta‑blockers: may enhance blood pressure lowering. - Calcium channel blockers: possible additive hypotensive effect. - Antidiabetic agents: risk of enhanced hypoglycemia. - CYP2C9 inhibitors (e.g., fluconazole): may increase irbesartan plasma concentrations.